<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">525</article-id><article-id pub-id-type="doi">10.25692/ACEN.2018.2.4</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of neuroinflammation in cognitive functions and social interaction in mice with age-dependent neurodegeneration</article-title><trans-title-group xml:lang="ru"><trans-title>Роль нейровоспаления в реализации когнитивных функций и социального взаимодействия у мышей с возрастзависимой нейродегенерацией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gorina</surname><given-names>Yana V.</given-names></name><name xml:lang="ru"><surname>Горина</surname><given-names>Яна Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>yana_20@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lopatina</surname><given-names>Olga L.</given-names></name><name xml:lang="ru"><surname>Лопатина</surname><given-names>Ольга Леонидовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>yana_20@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Komleva</surname><given-names>Yuliya K.</given-names></name><name xml:lang="ru"><surname>Комлева</surname><given-names>Юлия Константиновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>yana_20@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chernikh</surname><given-names>Anatolii I.</given-names></name><name xml:lang="ru"><surname>Черных</surname><given-names>Анатолий Иванович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>yana_20@bk.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Salmina</surname><given-names>Alla B.</given-names></name><name xml:lang="ru"><surname>Салмина</surname><given-names>Алла Борисовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>yana_20@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Voyno-Yasenetsky Krasnoyarsk State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Krasnoyarsk City Hospital No. 20 named after I.S. Berzon</institution></aff><aff><institution xml:lang="ru">КГБУЗ «Красноярская межрайонная клиническая больница № 20 им. И.С. Берзона»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-08-08" publication-format="electronic"><day>08</day><month>08</month><year>2018</year></pub-date><volume>12</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>27</fpage><lpage>32</lpage><history><date date-type="received" iso-8601-date="2018-08-09"><day>09</day><month>08</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Gorina Y.V., Lopatina O.L., Komleva Y.K., Chernikh A.I., Salmina A.B.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Gorina Y.V., Lopatina O.L., Komleva Y.K., Chernikh A.I., Salmina A.B.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Gorina Y.V., Lopatina O.L., Komleva Y.K., Chernikh A.I., Salmina A.B.</copyright-holder><copyright-holder xml:lang="ru">Gorina Y.V., Lopatina O.L., Komleva Y.K., Chernikh A.I., Salmina A.B.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/525">https://annaly-nevrologii.com/pathID/article/view/525</self-uri><abstract xml:lang="en"><p><bold>Introduction. </bold>Early activation of the innate immune response as a compensatory mechanism can lead to the damage of vessels and their dysfunction. This enables the development and progression of cognitive dysfunction, alteration of cerebral microcirculation, thus makes the onset of age-related neurodegenerative diseases possible. Inflammasomes of NLRP3 play the important role as far as they are triggers of the inflammatory process in age-related chronic neurodegenerative diseases.</p> <p><bold>Objectives. </bold>To study the development of social and cognitive impairments in aging NLRP3 knockout animals.</p> <p><bold>Material and methods. </bold>The experimental group was NLRP3 knockout (NLRP3-/-) male mice of the line B6.129S6-Nlrp3tm1Bhk / JJ) aged 12 months (n=10); control group – C57BL/6.SJL male mice aged 12 months (n=10). Neurobehavioral testing: “open field” test, “X-maze” test, “light-dark box”, three-chamber social test, and “five-trial social memory” test.</p> <p><bold>Results. </bold>In the “open field” test, when the social object appeared, NLRP3-/- animals spent less time at the center of the field I in comparison with the animals of the C57BL/6 line (p=0.013). NLRP3-/- animals spent more time in the black chamber compared to the animals in the control group (p=0.037) in the “light-dark box” test. In the “three-chamber social” test NLRP3-/- animals spent the same time both with the new and the already familiar social object (p=0.885). In the “five-trial social memory” test NLRP3-/- animals did not demonstrate reduction of interest towards individuals of the opposite sex in the fourth attempt compared to the first attempt.</p> <p><bold>Conclusion. </bold>NLRP3-/- mice have the increased levels of anxiety and inhibition, disruption of memory, and destructive changes in the field of social contacts and interactions. This indicates a disorder in the sphere of emotional behavior, as well as social memory</p></abstract><trans-abstract xml:lang="ru"><p>Введение. Ранняя активация врожденного иммунного ответа как компенсаторного механизма может привести к патологическому повреждению сосудов и их дисфункции, когнитивному снижению и нарушению церебральной микроциркуляции, тем самым создавая условия для возникновения возрастных нейродегенеративных заболеваний. Важная роль отводится инфламмасомам NLRP3 – триггерам воспалительного процесса при возрастных хронических нейродегенеративных заболеваниях.Цель исследования. Изучение развития социальных и когнитивных нарушений у стареющих NLRP3-нокаутных животных.Материалы и методы. Опытная группа – NLRP3-нокаутные (NLRP3-/-) мыши-самцы линии B6.129S6-Nlrp3tm1Bhk/JJ в возрасте 12 мес (n=10); контрольная группа – мыши-самцы линии C57BL/6×SJL в возрасте 12 мес (n=10). Нейроповеденческое тестирование: тесты «открытое поле», «приподнятый крестообразный лабиринт», «черно-белая камера», трехкамерный социальный, социальный пятипопыточный.Результаты. В тесте «открытое поле» при появлении социального объекта мыши NLRP3-/- меньше времени проводили в центре поля по сравнению с мышами линии C57BL/6 (р=0,013). В тесте «черно-белая камера» мыши NLRP3-/- больше времени проводили в черной камере по сравнению с мышами линии C57Bl/ (р=0,037). В трехкамерном социальном тесте у мышей NLRP3-/- время, проведенное с новым и с уже знакомым социальным объектом, не различалось (р=0,885). В социальном пятипопыточном тесте у мышей NLRP3-/- не выявлено снижения заинтересованности особью противоположного пола при сравнении 1-й и 4-й попыток.Заключение. У мышей NLRP3-/- повышен уровень тревожности и заторможенности, нарушено запоминание, выявлены деструктивные изменения в области социальных контактов и взаимодействий. Это свидетельствует о расстройстве в сфере эмоционального поведения, а также социальной памяти.</p></trans-abstract><kwd-group xml:lang="en"><kwd>NLRP3-mice</kwd><kwd>behavior</kwd><kwd>cerebrovascular inflammation</kwd><kwd>memory</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мыши NLRP3-/-</kwd><kwd>поведение</kwd><kwd>цереброваскулярное воспаление</kwd><kwd>память</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Green D.R., Galluzzi L., Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011; 333(6046): 1109–1112. DOI: 10.1126/science.1201940. PMID: 21868666.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Lumeng C.N., Liu J., Geletka L. et al. Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue. J Immunol 2011; 187(12): 6208–6216. DOI: 10.4049/jimmunol.1102188. PMID: 22075699.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Venegas C., Heneka M.T. Danger-associated molecular patterns in Alzheimer’s disease. J Leukoc Biol 2017; 101(1): 87–98. DOI: 10.1189/jlb.3MR0416-204R. PMID: 28049142.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Heneka M.T., Carson M.J., El Khoury J. et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol 2015; 14(4): 388–405. DOI: 10.1016/S1474-4422(15)70016-5. PMID: 25792098.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Zotova E., Bharambe V., Cheaveau M. et al. Inflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization. Brain J Neurol 2013; 136(Pt 9): 2677–2696. DOI: 10.1093/brain/awt210. PMID: 23943781.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Matarin M., Salih D.A., Yasvoina M. et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep 2015; 10(4): 633–44. DOI: 10.1016/j.celrep.2014.12.041. PMID: 25620700.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Heneka M.T. Inflammasome activation and innate immunity in Alzheimer’s disease. Brain Pathol 2017; 27(2): 220–222. DOI: 10.1111/bpa.12483. PMID: 28019679.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature 2012; 481(7381): 278–286. DOI: 10.1038/nature10759. PMID: 22258606.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ramanan V.K., Risacher S.L., Nho K. et al. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer’s disease implicates microglial activation gene IL1RAP. Brain J Neurol 2015; 138(Pt 10): 3076–3088. DOI: 10.1093/brain/awv231. PMID: 26268530.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Youm Y.H., Kanneganti T.D., Vandanmagsar B. et al. The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep 2012; 1(1): 56–68. DOI: 10.1016/j.celrep.2011.11.005. PMID: 22832107.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Vandanmagsar B., Youm Y.H., Ravussin A. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17(2): 179–88. DOI: 10.1038/nm.2279. PMID: 21217695.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Yu D., Corbett B., Yan Y. et al. Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer’s disease. Neurobiol Aging 2012; 33(12): 2942–2947. DOI: 10.1016/j.neurobiolaging.2012.02.023. PMID: 22440674.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Merlini M., Davalos D., Akassoglou K. In vivo imaging of the neurovascular unit in CNS disease. Intravital 2012; 1(2): 87–94. DOI: 10.4161/intv.22214. PMID: 25197615.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Gallart-Palau X., Serra A., Lee B.S.T. et al. Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer’s disease with cerebrovascular disease. J Neuroinflammation 2017; 14(1): 175. DOI: 10.1186/s12974-017-0946-y. PMID: 28865468.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Sato N., Morishita R. Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors. Front Aging Neurosci 2013; 5: 64. DOI: 10.3389/fnagi.2013.00064. PMID: 24204343.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Takeda S., Sato N., Morishita R. Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front Aging Neurosci 2014; 6: 171. DOI: 10.3389/fnagi.2014.00171. PMID: 25120476.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Takeda S., Sato N., Ikimura K. et al. Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiol Aging 2013; 34(8): 2064–2070. DOI: 10.1016/j.neurobiolaging.2013.02.010. PMID: 23561508.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Heneka M.T., Kummer M.P., Stutz A. et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 2013; 493(7434): 674–678. DOI: 10.1038/nature11729. PMID: 23254930.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Weinstock M. Prenatal stressors in rodents: Effects on behavior. Neurobiol Stress 2016; 6: 3–13. DOI: 10.1016/j.ynstr.2016.08.004. PMID: 28229104.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Gorina Y.V., Komleva Y.K., Lopatina O.L. et al. [The battery of tests for behavioral phenotyping of aging animals in the experiment]. Adv Gerontol 2017; 30(1): 49–55. PMID: 28557390.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Zhang M., Liu Y., Zhao M. et al. Depression and anxiety behaviour in a rat model of chronic migraine. J Headache Pain 2017; 18(1): 27. DOI: 10.1186/s10194-017-0736-z. PMID: 28224378.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Bourin M. Animal models for screening anxiolytic-like drugs: a perspective. Dialogues Clin Neurosci 2015; 17(3): 295–303. PMID: 26487810.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Yang M., Silverman J.L., Crawley J.N. Automated three-chambered social approach task for mice. Curr Protoc Neurosci 2011; 8: 8.26. DOI: 10.1002/0471142301.ns0826s56. PMID: 21732314.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Müller L., Weinert D. Individual recognition of social rank and social memory performance depends on a functional circadian system. Behav Processes 2016; 132: 85–93. DOI: 10.1016/j.beproc.2016.10.007. PMID: 27744087.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Olsen I., Singhrao S.K. Inflammasome involvement in Alzheimer’s disease. J Alzheimers Dis 2016; 54(1): 45–53. DOI: 10.3233/JAD-160197. PMID: 27314526.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Rovira-Llopis S., Apostolova N., Bañuls C. et al. Mitochondria, the NLRP3 inflammasome, and sirtuins in type 2 diabetes: new therapeutic targets. Antioxid Redox Signal 2018. DOI: 10.1089/ars.2017.7313. PMID: 29256638.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Karasawa T., Takahashi M. The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis. Inflamm Regen 2017; 37: 18. DOI: 10.1186/s41232-017-0050-9. PMID: 29259717.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Goto M. Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends 2008; 2(6): 218–230. PMID: 20103932.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Shrestha R., Millington O., Brewer J., Bushell T. Is central nervous system an immune-privileged site? Kathmandu Univ Med J 2013; 11(41):102–107. PMID: 23774427.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Quan N., Banks W.A. Brain-immune communication pathways. Brain Behav Immun 2007; 21(6): 727–735. DOI: 10.1016/j.bbi.2007.05.005. PMID: 17604598.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Kinnecom C., Lev M.H., Wendell L. et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007; 68(17): 1411–1416. DOI: 10.1212/01.wnl.0000260066.98681.2e. PMID: 17452586.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Koyama A., O’Brien J., Weuve J. The role of peripheral inflammatory markers in dementia and Alzheimer’s disease: a meta-analysis. J Gerontol A Biol Sci Med Sci 2013; 68(4): 433–440. DOI: 10.1093/gerona/gls187. PMID: 22982688.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Yang F., Wang Z., Wei X. et al. NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. J Cereb Blood Flow Metab 2014; 34(4): 660–667. DOI: 10.1038/jcbfm.2013.242. PMID: 24424382.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Youm Y.H., Grant R.W., McCabe L.R. et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 2013; 18(4): 519–532. DOI: 10.1016/j.cmet.2013.09.010. PMID: 24093676.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Osborn L.M., Kamphuis W., Wadman W.J., Hol E.M. Astrogliosis: an integral player in the pathogenesis of Alzheimer’s disease. Prog Neurobiol 2016; 144: 121–141. DOI: 10.1016/j.pneurobio.2016.01.001. PMID: 26797041.</mixed-citation></ref></ref-list></back></article>
